Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

Mesoporous silica nanoparticles with controlled loading of cationic dendrimer for gene delivery

Ph-Responsive Polydopamine Nanoparticles for Photothermally Promoted Gene Delivery

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Functional poly(dimethyl aminoethyl methacrylate) by combination of radical ring-opening polymerization and click chemistry for biomedical applications

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Polydopamine-based Nanoparticles with Excellent Biocompatibility for Photothermally Enhanced Gene Delivery

Facile Formation of PAMAM Dendrimer Nanoclusters for Enhanced Gene Delivery and Cancer Gene Therapy

Tunable membrane-penetrating bioreductive nanogels based on guanidinylated dendrimers for programmable gene delivery

Intelligent Drug Delivery System Based on Mesoporous Silica Nanoparticles Coated with an Ultra-pH-Sensitive Gatekeeper and Poly(ethylene Glycol).

Development of Supramolecular Pseudo-Block Conjugates Based on Star-Shaped Polycation for Dna Delivery

Mesoporous silica nanoparticles for drug and gene delivery

Functionalized Polyamidoamine Dendrimer as Gene Delivery Vectors

Dendronized Mesoporous Silica Nanoparticles Provide an Internal Endosomal Escape Mechanism for Successful Cytosolic Drug Release

Poly (amidoamine) (PAMAM) Dendrimer Mediated Delivery of Drug and Pdna/sirna for Cancer Therapy

Multi-responsive and Logic Controlled Release of DNA-gated Mesoporous Silica Vehicles Functionalized with Intercalators for Multiple Delivery.

PAMAM-Functionalized Cellulose Nanocrystals with Needle-Like Morphology for Effective Cancer Treatment

Efficient siRNA Delivery Using a Polyamidoamine Dendrimer with a Modified Pentaerythritol Core

Promising Plasmid DNA Vector Based on APTES-modified Silica Nanoparticles

Tuning charge density and crosslinking of precise amphiphilic oligo(ethanamino)amides for efficient and biocompatible gene delivery

Mesoporous Silica Nanoparticles As Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications

Preparation of PEI‐modified nanoparticles by dopamine self‐polymerization for efficient DNA delivery